[Elsevier] SAFETY AND EFFICACY RESULTS FROM A PHASE 1/2 CLINICAL TRIAL OF OCU400 MODIFIER GENE THERAPY FOR TREATMENT OF RETINITIS PIGMENTOSA |
|
This post will be closed automatically in 2026-08-29 01:27
Reward10points
|
post
reply
points
40
10
In-situ construction of amorphous每crystalline NiCo bimetallic oxyhydroxide for low-temperature supercapacitor device
10
In-situ construction of amorphous每crystalline NiCo bimetallic oxyhydroxide for low-temperature supercapacitor device
10
A privacy-preserving and byzantine-robust consensus for blockchain Federated Learning
10
A dissolving microneedle patch loaded with plumbagin/hydroxypropyl-汕-cyclodextrin inclusion complex for infected wound healing
10
International spillover effects in the EU's textile supply chains: A global SDG assessment
